Search results for: bisphosphonate

Persistent Symptomatic Hypocalcemia Due to Denosumab: A Case Review

Lyudmila Kirillova, MD, & William Ayoub, MD | October 1, 2014

Patients with osteoporosis and impaired renal function are at risk

Drugs Studied for Use in Rheumatoid Arthritis, Weight Loss

Michele B. Kaufman, PharmD, BCGP | August 1, 2014

Plus, rheumatology drug news from EULAR 2014

Lessons Learned from a Patient with Rheumatoid Arthritis

Sarah Troxell, RN, BSN | June 1, 2014

Sarah Troxell, RN, BSN, imparts what she’s learned about RA and medication management, assembling a team of health professionals and battling other health issues

New Osteoporosis Drugs Show Promise in Therapy Pipeline

Thomas R. Collins | June 1, 2014

Rheumatologists at the ACR’s State-of-the-Art Clinical Symposium in Chicago discuss medication alternatives to bisphosphonates that reduce bone resorption, build bone density and may provide new treatment options

New Insights into CPPD

Robert Terkeltaub, MD | October 1, 2013

Progress in research, outcomes, diagnosis, and treatment of calcium pyrophosphate dihydrate crystal deposition disease

Two Inflammatory Conditions—Polymyalgia Rheumatica and Giant Cell Arteritis—Share Clinical Connection

William P. Docken MD | March 1, 2013

Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) have common clinical and epidemiologic links, but they need not occur synchronously

ACR/ARHP Annual Meeting 2012: New Research Into Stem Cell Therapy and Drugs May Lead to Breakthrough Treatments for Osteoarthritis

Susan Bernstein | February 1, 2013

Novel strategies for treating osteoarthritis aim to relieve pain, rebuild or replenish deteriorated cartilage and bone, or to replace the joint through surgery